- NEWS AND VIEWS
Pancreatic cancer foiled by a switch of tumour subtype
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 557, 500-501 (2018)
doi: https://doi.org/10.1038/d41586-018-05129-6
References
Siegel, R. L., Miller, K. D. & Jemal, A. CA Cancer J. Clinicians 67, 7–30 (2017).
Bailey, P. et al. Nature 531, 47–52 (2016).
Collisson, E. A. et al. Nature Med. 17, 500–503 (2011).
Moffitt, R. A. et al. Nature Genet. 47, 1168–1178 (2015).
Andricovich, J. et al. Cancer Cell 33, 512–526 (2018).
Shi, J. & Vakoc, C. R. Mol. Cell 54, 728–736 (2014).
McDonald, O. G. et al. Nature Genet. 49, 367–376 (2017).
Roe, J.-S. et al. Cell 170, 875–888 (2017).
The Cancer Genome Atlas Research Network. Cancer Cell 32, 185–203 (2017).
Waddell, N. et al. Nature 518, 495-501 (2015).
Le, D. T. et al. N. Engl. J. Med. 372, 2509–2520 (2015).
Mazur, P. K. et al. Nature Med. 21, 1163–1171 (2015).